Диагностика и прогноз рассеянного склероза

1. Berger, J. R., and Sheremata, W. A. Persistent neurological deficit precipitated by hot bath test for multiple sclerosis. J.A.M.A. 249:1751, 1983.

2. Chiappa, К. H. Pattern shift visual, brainstem auditory, and short-latency somatosensory-evoked potentials in multiple sclerosis. Neurology (Minneapolis) 30:110, 1980.

3. dark, V. A., et al. Factors associated with a malignant or benign course of multiple sclerosis. J.A.M.A. 248:856, 1982.

4. Koopmans, R. A,, et al. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features. Ann. Neurol. 25:74, 1989.

5. Miller, D. H., Morrissey, S. B., and McDonald, W. 1. The prognostic significance of brain MRI at presentation with a single episode of suspected demyelination: A five year follow-up study. Neurology 42:427, 1992.

6. Nelson, L. M., et al. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. J.A.M.A. 259:3441, 1988.

7. Paty, D. W., et al. MRI in diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180,1988.

8. Percy, А. К., et al. Multiple sclerosis in Rochester, Minn.: A 60-year appraisal. Arch. Neurol. 25:105,1971.

9. Rudick, R. A., et al. Multiple sclerosis: The problem of incorrect diagnosis. Arch. Neurol. 43:578,1986.

10. Spencer, W. Suspicion of multiple sclerosis: To tell or not to tell? Arch. Neurol. 45:441,1988.

11. Troiano, R., et al. Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis. Ann. Neurol. 15:257, 1984.

12. Willoughby, E. W. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann. Neurol. 25:43, 1989.

13. Wolinsky, J. S. Multiple sclerosis. Curr. Neurol. 13:167, 1993.

Медикаментозная терапия рассеянного склероза

14. Chrouso, G. A., et al. Side effects ofglucocorticoid treatment: Experience of the optic neuritis treatment trial. J.A.M.A. 269:2110, 1993.

15. Compston, A. Methylprednisolone and multiple sclerosis. Arch. Neurol. 45:670,1988.

16. Duquette, P., et al. Interferon beta-1 В is effective in relapsing remitting multiple sclerosis: Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655, 1993

17. Hauser, S. L., et al. Intensive immunosuppression in progressive multiple sclerosis: A randomized, three-arm study of high-dose intravenous cycio-phosphamide, plasma exchange, and ACTH. N. Engl. J. Med. 308:173, 1983.

18. Kappos, L., et al. Cyclosporine versus azathioprine in the longterm treatment of multiple sclerosis: Results of The German Multicenter Study. Ann. Neurol. 23:56,1988.

19. Killian, J. M., et al. Controlled pilot trial of monthly intravenous cycio-phosphamide in multiple sclerosis. Arch. Neurol. 45:27, 1988.

20. Menken. M. Consensus and controversy in neurologic practice: The case of steroid treatment in multiple sclerosis. Arch. Neurol. 46:322, 1989.

21. Weiner. H. L., and Hafler, P. A. Immunotherapy of multiple sclerosis. Ann. Neurol. 23:211,1988.

Изменения спинномозговой жидкости при рассеянном склерозе

22. Caroscio, J. Т., et al. Quantitative CSF lgG measurements in multiple sclerosis and other neurological diseases: An update. Arch. Neurol. 40:409,1983.

23. Farlow, M. R., et al. Multiple sclerosis: Magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis. Neurology (Minneapolis), 36:828,1986.

24. Farrell, M. A., et al. Oligoclonal bands in multiple sclerosis: Clinical-pathologic correlation. Neurology (Minneapolis) 35:212, 1985.

25. Gerson, В., et al. Myelin basic protein, oligoclonal bands, and lgG in cere-brospinal fluid as indicators of multiple sclerosis. Clin. Chem. 27:1974, 1981.

26. Johnson, К. P. Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis. Neurology (Minneapolis) 3:106, 1980.

27. Schapira, К.. Is lumbar puncture harmful in multiple sclerosis? J. Neurol. Neurosurg. Psychiatry 22:238,1959.

Слабость и спастичность при рассеянном склерозе

28. Coffey, R. J., et al. Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. J. Neurosurgery 78:226. 1993.

29. Duncan, G. W., Shahani, В. Т., and Young, R. R. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. Neurology (Minneapolis) 26:441,1976.

30. Gelenberg, A. J., and Poskanzer, D. C. The effects ofdantrolene sodium on spasticity in multiple sclerosis. Neurology (Minneapolis) 23:1313,1973.

31. Lenman. J. A. R. A clinical and experimental study of the effects of exercise on motor weakness in neurological disease. J. Neurol. Neurosurg Psychiatry 22:182,1959.

32. Levine, 1., et al. Diazepam in the treatment of spasticity: A preliminary quantitative evaluation. J. Chronic Dis. 22:57, 1969.

33. Liversedge, L. A., and Maher, R. M. Use of phenol in relief of spasticity Br. Med. J. 2:31, 1960.

34. Selker, R., Greenberg, A., and Marshall, M. Anterior rhizotomy for flexor spasms and contractures of the legs secondary to multiple sclerosis. Ann Surg. 162:298,1965.

Нарушения мочеиспускания, дефекации и половой функции при рассеянном склерозе

35. Betts, С. D., Dmellow, M. Т., and Fowler, С. J. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 56:245, 1993.

36. Blaivas, J. G. Management of bladder dysfunction in multiple sclerosis. Neurology (Minneapolis) 30:12,1980.

37. Massey, E. W., and Pleet, A. Penile prosthesis for impotence in multiple sclerosis. Ann. Neurol. 6:451, 1979.

38. Peterson, Т., and Pedersen, E. Neurodynamic evaluation of voiding dysfunction in multiple sclerosis. Acta Neurol. Scand. 69:402, 1984.

39. Tarabulcy, E. Bladder disturbances in multiple sclerosis and their management. Mod. Treat. 7:941,1970.

40. Vas, С. J. Sexual impotence and some autonomic disturbances in men with multiple sclerosis. Acta Neurol. Scand. 45:166, 1969.

Психические нарушения при рассеянном склерозе

41. Beatly, W. W., et al. Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Arch. Neurol. 45:611, 1988.

42. Krupp, L, В., et al. Fatigue in multiple sclerosis. Arch. Neurol. 45:435, 1988.

43. Peyser, J. M., et al. Cognitive function in patients with multiple sclerosis Arch. Neurol. 37:577,1980.

44. Rosenberg, G. A., and Appenzeller, 0. Amantadine, fatigue, and multiple sclerosis. Arch. Neurol. 45:1104, 1988.

45. Schiffer, R. В. The spectrum of depression in multiple sclerosis. Arch. Neurol. 44:596,1987.

46. Weinshenker, В. G., et al. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 42:1468 1992.

Тремор и атаксия при рассеянном склерозе

47. Cooper, 1. S. Relief of intention tremor of multiple sclerosis by thalamic surgery. J.A.M.A. 199:689,1967.

48. Goidman, M. S., and Kelly, P. J. Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J. Neurosurgery 77:223,1992.

49. Hewer, R. L., Cooper, R., and Morgan, H. An investigation into the value of treating intention tremor by weighting the affected limb. Brain 95:579, 1972.

Болевые синдромы при рассеянном склерозе

50. Albert, M. Treatment of pain in multiple sclerosis: A preliminary report. N. Engi, J. Med. 280:1395, 1969.

51. Chakravorty, В. Association of trigeminal neuralgia with multiple sclerosis. Arch. Neurol. 14:95,1966.

52. Moulin, D. E. Pain syndromes in multiple sclerosis. Neurology (Minneapolis) 38:1830,1988.

Неврит зрительного нерва

53. Beck, R. W„ et al. A randomized controlled trial ofcorticosteroids in the treatment of optic neuritis. N. Engi. J. Med. 326:581, 1992.

54. Bradley, W. G., and Whitty, C. W. M. Acute optic neuritis: Prognosis for development of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 31:10, 1968.

55. Compston, D. A. S., et al. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 101:495, 1978.

56. Feinsod, M., and Hoyt, W. F. Subclinical optic neuropathy in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 38:1109, 1975.

57. Jacobson, D. M. Optic neuritis in the elderly: Prognosis for visual recovery and long-term follow-up. Neurology (Minneapolis) 38:1834, 1988.

58. Miller, D. H., et al. The early risk of multiple sclerosis after optic neuritis. J. Neurol. Neurosurg. Psychiatry 51:1569, 1988.

59. Rizzo, J. F., and Lessell, S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: A long-term prospective study. Neurology (Minneapolis) 38:185,1988.

Острый рассеянный энцефаломиелит

60. Alvord, E. С. Acute Disseminated Encephalomyelitis and “Allergic” Neuroencephalopathies. In P. J. Vinken and G. W. Bruyn (eds.). Handbook of Clinical Neurology. Amsterdam: North-Holland, 1970. Vol. 9, pp. 500— 571

61. Johnson, R. Т., Griffin, D. E„ and Gendelman, H. E. Post-infectious encephalomyelitis. Semin. Neurol. 5:180,1985.

62. Kesselring, J., et al. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis. Brain 113:291, 1990.

63. Pasternak, J. F., deVivo, D. C., and Prensky, A. L. Steroid-responsive encephalomyelitis in childhood. Neurology (Minneapolis) 30:481, 1980.

64. Scott, Т. F. Post-infectious and vaccinial encephalitis. Med. Clin. North Am. 51:701,1967.

65. Selling, В., and Meilman, E. Acute disseminated encephalomyelitis treated with ACTH. N. Engi. J. Med. 253:275, 1955.

Острый поперечный миелит

66. Ropper, A. H., and Poskanzer, D. C. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann. Neurol 4:51,1978.

67. Tyor, W. R. Post-infectious Encephalomyelitis and Transverse Myelitis. In R. T. Johnson and J. W. Griffin (eds.), Current Therapy for Neurologic Disease (4th ed.). St. Louis: Mosby-Yearbook, 1993.


Материал предоставил Голованов М.Ю.

Назад    К оглавлению    К меню